NCT07504497 is a Phase 4 clinical trial of dexmedetomidine Lidocaine Saline in FESS Operation, sponsored by Younes Ahmed Younes.

Who is sponsoring NCT07504497?

NCT07504497 is sponsored by Younes Ahmed Younes.

What drugs are being tested in NCT07504497?

Interventions in NCT07504497: dexmedetomidine Lidocaine Saline.

What condition does NCT07504497 study?

NCT07504497 studies FESS Operation.

Is NCT07504497 still recruiting?

NCT07504497 is currently not yet recruiting. Last updated 31 March 2026.

Last reviewed 2026-03-31 · How we verify

NCT07504497

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intratracheal Dexmedetomidine Versus Lidocaine for Smooth Tracheal Extubation

Not yet recruiting Phase 4 Last updated 31 March 2026

What this trial tests

Phase 4 trial testing dexmedetomidine Lidocaine Saline in FESS Operation in 120 participants. Not yet recruiting.

Timeline

15 April 2026

Primary endpoint
15 December 2026

15 December 2026

Quick facts

Lead sponsor	Younes Ahmed Younes
Phase	Phase 4
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	120
Start date	15 April 2026
Primary completion	15 December 2026
Estimated completion	15 December 2026

Drugs / interventions tested

dexmedetomidine Lidocaine Saline

Conditions studied

FESS Operation — all drugs for FESS Operation →

Sponsor

Younes Ahmed Younes

Who can join

Adults 18 to 60, any sex, with FESS Operation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

compare the efficacy of intratracheal dexmedetomidine versus intratracheal lidocaine in achieving smooth tracheal extubation in patients undergoing Functional Endoscopic Sinus surgery and reconstructive nasal surgeries under general anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07504497 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Younes Ahmed Younes
Last refreshed: 31 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07504497.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing